Lets change that together
Semaglutide improves glycemic control by enhancing insulin sensitivity and reducing glucose production in the liver
As a potent acylated peptide, BI 456906 incorporates a C18 fatty acid to prolong its half-life and maintains stability against DPP-4 proteolytic degradation through C-terminal amidation and substitution at the second amino acid [109]
The most commonly reported changes after stopping GLP-1 medications include: Return of appetite : The appetite-suppressing effects diminish, and many people notice increased hunger and food cravings returning to pre-treatment levels Weight regain : Clinical evidence consistently shows that most individuals regain weight after discontinuation, often within 312 months Rising blood glucose levels : For those with type 2 diabetes, HbA1c levels typically increase, sometimes returning to pre-treatment values Changes in eating patterns : Gastric emptying returns to normal speed, which may affect feelings of fullness after meals It's important to note that stopping GLP-1 medications is generally safe from a withdrawal perspectivethese drugs do not cause physical dependence or withdrawal symptoms in the way some medications do, and tapering is not typically required
Kuang W, et al
Over the course of 72 weeks, people on tirzepatide lost an average of 20.2% of their body weight, or about 50 pounds
